title: Long-term day-case treatment of peripheral neuromuscular disease with intravenous immunoglobulin: the practice of a regional day-case service in Preston, Lancashire.
abstract: Neuromuscular disease is one of the most common indications for the use of intravenous immuno-globulin (IVIG). We describe practical aspects of IVIG administration and dosing in long-term treatment, as well as the setting up of a day-case service in a regional neurology unit to provide a streamlined patient experience. An audit of the safety of IVIG administration and patient satisfaction during implementation supported the fact that this is a relatively safe treatment. Standardised assessment methods have been used both to monitor treatment effect and to provide the necessary outcome measures for Department of Health (DOH) monitoring of IVIG use.
authors.affiliation: Department of Neurology, Royal Preston Hospital, Preston, UK. John.Nixon@lthtr.nhs.uk
authors.forename: John
authors.initials: J
authors.lastname: Nixon
authors.forename: Claire
authors.initials: C
authors.lastname: McHugh
authors.forename: Sam
authors.initials: S
authors.lastname: Jones
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003631:Day Care, Medical / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007155:Immunologic Factors / Q000008:administration & dosage; D008134:Long-Term Care / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009468:Neuromuscular Diseases / Q000188:drug therapy*; D017060:Patient Satisfaction; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D006113:United Kingdom; D055815:Young Adult
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors
keywords: Intravenous immunoglobulin; day-case treatment; neuromuscular disease
references.citation: J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):106-9
references.pmid: 9221978
references.citation: Muscle Nerve. 2008 Mar;37(3):406-9
references.pmid: 17918749
references.citation: J Peripher Nerv Syst. 2009 Jun;14(2):93-100
references.pmid: 19691531
references.citation: J Clin Immunol. 2010 May;30 Suppl 1:S84-9
references.pmid: 20387103
references.citation: Eur J Neurol. 2010 Feb;17(2):289-94
references.pmid: 19863650
references.citation: Pract Neurol. 2010 Dec;10(6):351-4
references.pmid: 21097834
references.citation: Lupus. 2005;14(10):802-8
references.pmid: 16302674